SSO Partners with SABCS to Enhance Surgical Oncology Programming

Share on facebook
Share on twitter
Share on linkedin

SSan Antonio Breast Cancer Symposium logoan Antonio Breast Cancer Symposium has partnered with SSO to present the educational session, Multidisciplinary Approach to Optimizing Local Regional Therapy in Hormone Receptor Positive Breast Cancer, moderated by Armando E. Giuliano, MD on Tuesday, December 10, 2019.

Most of the presentations at SABCS focus on the latest clinical and basic research results relating to breast cancer. By contrast, educational sessions are designed to inform and update those interested in a review on a particular topic. Although these sessions may include new specific research findings, their primary intent is to offer summaries of existing knowledge, and to provide background for some of the active areas which will be discussed in the rest of the meeting.

The educational session will feature three presentations as follows:

Neoadjuvant therapy for hormone receptor positive breast cancer: Challenges and advances 
Otto Metzger, MD, Dana-Farber Cancer Institute, Boston, MA

Surgical management of the upfront surgery patient
Melissa L. Pilewskie, MD, Memorial Sloan Kettering Cancer Center New York, NY

Local regional therapy considerations after preoperative therapy in hormone receptor positive breast cancer
Tari Ann King, MD, Dana-Farber Cancer Institute Brigham and Women’s Cancer Center Boston, MA

As part of SSO’s partnership with SABCS, SSO member Elizabeth Mittendorf, MD, Dana Farber Cancer Institute/Brigham and Women’s Cancer Center, was appointed to serve on the SABCS Program Planning Committee with the focus of surgical oncology.  In addition, SSO members served as SABCS abstract reviewers for related categories. SABCS takes place December 10 – 14, 2019 in San Antonio, TX. Visit www.SABCS.org for program information and to register.

Scroll to Top